期刊文献+

他汀类药物调节凝血功能及其机制 被引量:1

Statins Regulating the Blood Coagulation Cascade and Its Mechanism
下载PDF
导出
摘要 已经证实他汀类药物的多效性对心血管具有明显的保护作用,他汀类药物从多个水平调节凝血级联反应,包括抑制凝血酶催化的凝血反应,以及增强凝血抑制物的抗凝作用,从而起到抗血栓作用。他汀类药物的多效性大多与其降低胆固醇的作用无关,其调节凝血级联反应的机制主要是抑制信号蛋白的异戊二烯化。 The pleiotropic effects of statins have been shown to play a protective role in cardiovascular disease. Increasingly, studies have indicated that statins can regulate the blood coagulation cascade in multiple ways, including the inhibition of the coagulant reactions catalyzed by thrombin leading to reduced thrombogenicity. The pleiotropic effects of statins, however, are poorly correlated with cholesterol lowering. Nevertheless, the mechanisms of regulation are mainly attributed to the inhibition of the isoprenylation of signal proteins such as Rho/ Rhoase.
出处 《心血管病学进展》 CAS 2009年第4期656-659,共4页 Advances in Cardiovascular Diseases
关键词 他汀类药物 凝血反应 凝血因子 statins blood coagulation cascade coagulation factors
  • 相关文献

参考文献25

  • 1Calabro P,Yeh ET.Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor:beyond cardiovascular diseases[J].Curr Atheroscler Rep,2004,6:36-41. 被引量:1
  • 2Jean D.Beneficial cardiovascular pleiotropic effects of statins[J].Circulation,2004,109:Ⅲ39-Ⅲ43. 被引量:1
  • 3Undas A,Brummel Z,Kathleen E,et al.Statins and blood coagulation[J].Arterioscler Thromb Vasc Biol,2005,25(2):287-294. 被引量:1
  • 4Niemetz J,Fallon JT,Harrington E,et al.Rapid generation of thrombin by atheroma and platelets[J].J Thromb Haemost,2004,2:321-326. 被引量:1
  • 5Nagata K,Ishibashi T,Sakamoto T,et al.Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes[J].Atherosclerosis,2002,163:39-47. 被引量:1
  • 6Sabine S,Walter SS,Johannes P,et al.Simvastatin blunts endotoxin-induced tissue factor in vivo[J].Circulation,2005,111(14):1841-1846. 被引量:1
  • 7黄全跃,赵水平,吴洪光,周宏年,李江,罗小岚.不同剂量辛伐他汀对急性冠状动脉综合征患者组织因子和组织因子途径抑制物的影响[J].中国动脉硬化杂志,2005,13(5):633-635. 被引量:11
  • 8Morishita E,Minami S,Ishino C,et al.Atorvastatin reduces plasma levels of factor Ⅶ activity and factor Ⅶ antigen in patients with hyperlipidemia[J].J Atheroscler Thromb,2002,9:72-77. 被引量:1
  • 9Porreca E,DiFebbo C,Amore C,et al.Effect of lipid-lowering treatment on factor Ⅶ profile in hyperlipidemic patients[J].Thromb Haemost,2000,84:789-793. 被引量:1
  • 10Undas A,Brummel KE,Musial J,et al.Simvastatin depresses blood clotting by inhibiting activation of prothrombin,factor V,and factor ⅩⅢ and by enhancing factor Va inactivation[J].Circulation,2001,103:2248-2253. 被引量:1

二级参考文献13

  • 1Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation, 2003, 108: 2 684-689. 被引量:1
  • 2Tsiara S, Elisaf M, Michailidis DP. Early vascular benefits of statin therapy. Curr Med Res Opin, 2003, 19: 540-556. 被引量:1
  • 3Kaikita ML, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K, et al. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol, 1999, 103: 879-887. 被引量:1
  • 4Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J, 1997, 134: 253-259. 被引量:1
  • 5Son JW, Koh KK, Ahn JY, Jin DK, Kin HS, Choi YM, et al. Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Int J Cardiol, 2003, 88(1): 77-82. 被引量:1
  • 6Seljeflot I, Tonstad S, Hjermann I, Arnesen H. Improved fobrinolysis after 1-year treatment with HMG-CoA reductase inhibitors in patients with coronary disease. Thromb Res, 2002, 105: 285-290. 被引量:1
  • 7Morange PE, Simon C, Alessi MC, Luc G, Arvetler D, Ferrieres J. Endothelial cell markers and the risk of coronary heart disease. The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Circulation, 2004, 109: 1 343-348. 被引量:1
  • 8Maly M, Vojacek J, Hrabos V, Kvasnicka J, Salaj P, Durdil V. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndromes. Physiol Res, 2003, 52: 719-728. 被引量:1
  • 9Sandest PM, Lund H, Norseth J, Abildgaard U, Ose L. Treament with hydroxymethylglutaryl-Coenzyme A reductase inhibitori in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb, 1991, 11: 138-145. 被引量:1
  • 10Brown JR, Kuter DJ. The effect of unfractionated vs low molecular weight heparin on tissue factor pathway inhibitor levels in hospital patients. Thromb Haemost, 2001, 85: 979-985. 被引量:1

共引文献31

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部